Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent Aerosol in Moderate to Severe Asthma Crisis
NCT02182700Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1998
- Primary completion
- Dec 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of salbutamol, ipratropium bromide in asthma, sponsored by Boehringer Ingelheim. Started Jul 1998; status: terminated.
02
Drugs
salbutamolipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02182700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182700.